Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0364019910240010072
Korean Journal of Thoracic and Cardiovascular Surgery
1991 Volume.24 No. 1 p.72 ~ p.82
Clinical Evaluation of Lung Cancer





Abstract
From May 1978 to Sep. 1990, 106 patients who had been diagnosed as primary lung cater and operated on at the Department of Thoracic & Cardiovascular Surgery, HanYang University, were clinically evaluated.
1. The peak incidence of age was 5th decade of life(37.7%) and 6th decade (29.2%). Male to female ratio was 3.8 : 1.
2. Most of symptoms were respiratory, which were cough, chest pain; hemoptysis, and asymptomatic cases were 2.90.
3. Histopathologic classifcations were squamous cell carcinoma(53.7%), adenocarcinoma (23.8%), bronchioalveoler¢¥carcinoma(6.6%), undifferentiated large cell carcinoma (6.6%), small cell carcinoma(3.8%), adenosquamous carcinoma(3.8%) and others(1.8ao).
4. Methods of operation were pneumonectomy 49.1%(52cases), lobectomy 21%(22cases) bilobectomy(6cases), lobectomy with wedge resection(3cases), exploration 21.9%(23cases), and resectability was 78.3%.
5. Staging classifications were Stage I (22.6%), Stage II (11.3%), Stage Ma(42.5%), Stage lff b(21.7%) and Stage1V (1.9%). Resectability by Stage : Stage I was 10010o, II 10001o, M a 84.4% and III b 30.0/o.
6. Causes of most of inoperable cases were invasion of mediastinal steuctures and diffuse chest wall, and others were contralateral lymph node invasion and malignant pleural effusion.
7. Operative mortality was 6.7% which caused by arrhythmia, sepsis, pulmonary edema, and radiation pneumonitis.
8. On the long term follow up of the resectable cases, overall 1 year survival rate was 58.5 %, 2 year 39%, and 5 year 19.5%. Five year survival rate was 40% in Stage 1, 25% in Stage 11 and 11.7% in Stage Ma. As for the method of operation, the higher 5 year survival rate was observed in lobectomies(33.3%) than in pneumonectomies(10.3%).
KEYWORD
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø